On Cancer

Search by keywords:

and/or
Show search filters

Explore by tags:

810 Blog posts found

In the Lab

Why a New Immunotherapy for Lung Cancer Works for Only Some People

According to an MSK study, a powerful immunotherapy drug for lung cancer works better in people whose tumors carry a lot of mutations caused by tobacco smoke.

Cancer genomics researcher Timothy Chan

Prevention

Colorectal Cancer Screening Prevents Cancer, Saves Lives

Having a regular screening colonoscopy is your best defense against colon and rectal cancer.

A patient lies on an exam table while doctors in scrubs prepare to perform a colonoscopy.

In the Lab

Outsmarting Cancer’s Survival Skills

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.

MSK investigators Joan Massagué and Anna Obenauf

Learning Curve

Teaching Doctors to Think Like Patients

Memorial Sloan Kettering’s Comskil program helps doctors improve their communication skills — and their relationships with their patients.

A doctor speaks with his patient in an exam room.

Feature

The Future of Cancer: Five Reasons for Optimism

Learn about five hot science areas that are changing the way we understand and treat cancer.

In the Clinic

“Living Therapies” Developed at MSK Provide New Approach for Cancer Treatment

Cell therapies that use patients’ own immune cells to attack cancer are a promising and rapidly growing area of research.

CAR T cell immunotherapy

Event

Three Days in the Life of Memorial Sloan Kettering

While you’re watching the three-part Cancer: The Emperor of All Maladies, here’s an idea of what we’re doing to care for our patients.

Three Days in the Life of Memorial Sloan Kettering

Event

Considering the Human Side — and the History — of Cancer

MSK employees previewed the upcoming documentary Cancer: The Emperor of All Maladies, which features several of our scientists and their research.

Pictured: Teresa Gilewski and filmmaker Barak Goodman

Decoder

What Are Exceptional Responders?

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Exceptional responders of new drugs in clinical trials.

Q & A

Why Might A Woman Have Her Ovaries Removed?

Women can use the results of genetic tests to make informed decisions about ovary removal to reduce cancer risk.

Megan Harlan Fleischut and Kenneth Offit